Literature DB >> 17556871

Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

N A Shah1, I A Urusova, A D'Agnolo, S D Colquhoun, B E Rosenbloom, S L Vener, S A Geller, M Younes, J Lechago, A P Heaney.   

Abstract

Hepatic carcinoid tumors are very uncommon; most are clinically non-functional and very few present with the symptoms of carcinoid syndrome. ACTH-producing carcinoid tumors most commonly originate in the lung or thymus and present insidiously with bronchospasm and/or chest mass. Occasionally, ectopic ACTH syndromes have been reported in association with pancreatic islet cell tumors, medullary thyroid cancer, pheochromocytoma, small-cell lung carcinoma, and rarely, ovarian and prostate tumors. We report here a patient with an ectopic ACTH-secreting primary hepatic carcinoid tumor who presented with cushingoid appearance, profound proximal muscle weakness, severe lower extremity edema, and markedly elevated urinary free cortisol. ACTH levels were in the low normal range. A solitary vascular hepatic lesion was found on magnetic resonance imaging, which was isodense with the surrounding liver on octreotide scan and photopenic on an 18-fluorodeoxyglucose (18FDG)-positron emission tomography (PET) scan. Following surgical resection of the hepatic tumor, histopathology confirmed an ACTH-secreting neuroendocrine tumor (NET), the patient had complete resolution of hypercortisolemic symptoms and remains in remission, now 4 yr after hepatic tumor resection. This case reports the first ACTH-secreting primary hepatic NET presenting as ectopic Cushing's syndrome. Interesting aspects of this case include the presence of a pituitary incidentaloma, the low normal ACTH, and photopenia on 18FDG-PET imaging.

Entities:  

Mesh:

Year:  2007        PMID: 17556871     DOI: 10.1007/BF03346308

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Characterisation of ACTH related peptides in ectopic Cushing's syndrome.

Authors:  Robert L Oliver; Julian R E Davis; Anne White
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 2.  Primary hepatic carcinoid tumor: case report and review of 53 cases.

Authors:  M Iwao; M Nakamuta; M Enjoji; H Kubo; T Fukutomi; Y Tanabe; H Nishi; K I Taguchi; K Kotoh; H Nawata
Journal:  Med Sci Monit       Date:  2001 Jul-Aug

Review 3.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

4.  Cholangiocarcinoma: a clinicopathologic study of five cases with ultrastructural observations.

Authors:  L I Alpert; F G Zak; S Werthamer; J F Bochetto
Journal:  Hum Pathol       Date:  1974-11       Impact factor: 3.466

Review 5.  Ectopic adrenocorticotropic hormone syndrome.

Authors:  B L Wajchenberg; B B Mendonca; B Liberman; M A Pereira; P C Carneiro; A Wakamatsu; M A Kirschner
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

Review 6.  Developments in PET for the detection of endocrine tumours.

Authors:  B Eriksson; H Orlefors; K Oberg; A Sundin; M Bergström; B Långström
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-06       Impact factor: 4.690

7.  Somatostatin-receptor imaging in the localization of endocrine tumors.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

8.  Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors.

Authors:  D Vieau; N G Seidah; M Mbikay; M Chrétien; X Bertagna
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

9.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

10.  The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.

Authors:  Karel Pacak; Ioannis Ilias; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

View more
  15 in total

1.  Possible ACTH-independent, cortisol-secreting and DHEA-secreting metastatic hepatocellular carcinoma causing Cushing's syndrome.

Authors:  Alan Sacerdote; Taiga Inoue; Nithin Thomas; Gul Bahtiyar
Journal:  BMJ Case Rep       Date:  2015-12-23

2.  Altered FDG uptake patterns in pediatric lymphoblastic lymphoma patients receiving induction chemotherapy that includes very high dose corticosteroids.

Authors:  Susan E Sharp; Michael J Gelfand; Michael J Absalon
Journal:  Pediatr Radiol       Date:  2011-09-01

3.  Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: clinical implications of a rare association.

Authors:  M Filippella; M V Davì; G Doveri; E Lillaz; A Ciccarelli; E Massimetti; M Toaiari; M Falconi; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2010-04-12       Impact factor: 4.256

Review 4.  The ectopic ACTH syndrome.

Authors:  Krystallenia I Alexandraki; Ashley B Grossman
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 5.  Characteristics of common solid liver lesions and recommendations for diagnostic workup.

Authors:  Nimer Assy; Gattas Nasser; Agness Djibre; Zaza Beniashvili; Saad Elias; Jamal Zidan
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

6.  Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life.

Authors:  Susan G Coe; Winston W Tan; Thomas P Fox
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

Review 7.  18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.

Authors:  Sona Balogova; Jean-Noël Talbot; Valérie Nataf; Laure Michaud; Virginie Huchet; Khaldoun Kerrou; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-16       Impact factor: 9.236

8.  Imaging findings of primary hepatic carcinoid tumor with an emphasis on MR imaging: case study.

Authors:  Makoto Ichiki; Norifumi Nishida; Akira Furukawa; Shuzo Kanasaki; Shinichi Ohta; Yukio Miki
Journal:  Springerplus       Date:  2014-10-17

Review 9.  Primary hepatic carcinoid tumor: case report and literature review.

Authors:  Éden Sartor Camargo; Marcelo de Melo Viveiros; Isaac José Felippe Corrêa Neto; Laercio Robles; Marcelo Bruno Rezende
Journal:  Einstein (Sao Paulo)       Date:  2014-11-18

Review 10.  Primary carcinoid tumors of the liver.

Authors:  Gary Schwartz; Agnes Colanta; Harold Gaetz; John Olichney; Fadi Attiyeh
Journal:  World J Surg Oncol       Date:  2008-08-27       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.